Sino Biopharmaceutical Limited (SBMFF) Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | -1.42 | -0.32 | -0.18 | -0.44 | -0.22 | ||||
Changes by years, y/y, % | -9% | -78% | -42% | +137% | -50% | -32.4% |
Sino Biopharmaceutical Limited. Debt/EBITDA
Sino Biopharmaceutical Limited. Debt/EBITDA, changes, %
Sino Biopharmaceutical Limited (SBMFF) Debt/EBITDA US GAAP (quarter values) |
||||||||
2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | LTM ? | |||
Debt/EBITDA | -0.60 | -0.85 | -0.84 | -0.30 | -0.31 | |||
Changes by years, y/y, % | -20% | +13% | -91% | -48% | ||||
Changes by quarters, q/q, % | -83% | +42% | -1% | -64% | +4% |